CDXS
Codexis, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Alison Moore
IPO Date
2010-04-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Codexis, Inc.
CEO
Alison Moore
IPO Date
2010-04-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 66,350 |
| $2.48 |
| 18 Jun 2026 | Richards Christos | director | A-Award | Acquired | 66,350 | $2.48 |
| 18 Jun 2026 | Smith David V | director | A-Award | Acquired | 66,350 | $2.48 |
| 18 Jun 2026 | Singhvi Rahul | director | A-Award | Acquired | 66,350 | $2.48 |
| 18 Jun 2026 | Martinborough Esther | director | A-Award | Acquired | 66,350 | $2.48 |
| 18 Jun 2026 | DILLY STEPHEN GEORGE | director | A-Award | Acquired | 66,350 | $2.48 |
| 18 Jun 2026 | De Vre Raymond | director | A-Award | Acquired | 66,350 | $2.48 |
| 11 Jun 2026 | De Vre Raymond | director | S-Sale | Disposed | 2,605 | $2.37 |
| 25 Feb 2026 | Lutz Stefan | Chief Scientific Officer | A-Award | Acquired | 316,100 | $1.07 |